...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: ESPR got crushed today
1
bfw
May 02, 2018 05:51PM
5
May 02, 2018 07:25PM
3
bfw
May 02, 2018 08:47PM
4
May 02, 2018 09:03PM

The reality is that many that believe the LDL hypothesis take it to the extreme that targeting LDL reduction is the only way to attack MACE (other than BP/smoking/diabetes).

There is evidently correlation between lower LDL and reduced MACE. Many would certainly argue causation. However, we are likely reaching the law of diminishing returns.

ESPRs drug faces a long road to approval IMHO and may not have a big market waiting for it depending on PKSC9 prices down the road.

At least RVX has endeavoured to fund a Phase 3 trial which will give important MACE data.

ESPR management has proceeded cautiously and just got stung by the results of their “pivotal” trial.

ESPR should not still have a market cap over $1 Billion. On IV, I called it a short at $70 and I should have ate my own cooking.

 

bfw


May 03, 2018 08:29AM
2
May 03, 2018 02:46PM
3
May 03, 2018 04:20PM
1
May 03, 2018 04:42PM
2
May 07, 2018 03:11PM
Share
New Message
Please login to post a reply